Nangona mhlawumbi kungekho kwiklasi efanayo yesigqibo njengoko unquma ukuba okanye ungayi kunamncelisa, ukhetha i-formula yomntwana ingaba nzima, nayo.
Iinkampani zefomula ze-Baby asenza kube lula xa ziqhubeka nokuphuma kunye namafomula omtsha, ngamnye kuthiwa angcono kunabo bonke abanye.
Baby Formula Brands
Enye yezinto zokuqala oza kuyenza xa ukhetha i-formula yomntwana ikhetha isigqibo sokuba yeyiphi i-brand brand brand to buy.
Ngokuqhelekileyo, khumbula ukuba zonke iimpawu zefomula kunye nosana ezisethengiswayo eUnited States kufuneka zihlangabezane neemfuno ezisemgangathweni zomthetho we-Federal Food, i-Drug and Cosmetic Act ('I-Forms Formula Act') kunye nemigaqo ye-FDA.
Oko akuthethi ukuba zonke iimpawu zefomula zentsana ziyafana, kodwa nayiphi na imveliso emikhulu, njenge-Enfamil, Similac, okanye iNestle Good Start, kunye neempahla zesitolo ezivela kwi-Walmart, Target, okanye iKroger, njl., Kufuneka zihlangabezane nomntwana wakho neemfuno zesondlo.
Iintlobo ze-Baby Formula
Kukho iintlobo zeendlela ezisisiseko, kuquka:
- Ifom ye-milk-based based formula - uhlobo lwefom efunekayo ukuba umntwana oqhelekileyo angabikho kwi-breastfed (imizekelo: Enfamil Lipil, Nestle Good Start Start Gentle Plus, i-Similac Advance)
- Ifomula "encinci" ene-lactose encinci kunokuba i-formula ehlala rhoqo yobisi - kubantwana abanegesi okanye ubuncwane kwi-formula-based based formula (imizekelo: Enfamil Gentlease Lipil kunye neNestle Good Start Start Gentle Plus)
- Ifomousse-free-formula - kwiintsana ezinokuxhaswa kwe-lactose (imizekelo: Enfamil LactoFree Lipil kunye neSimilac Inomdla
- Uhlobo lwe-starch lomnxeba olongezelelweyo - kwiintsana ezine-acid reflux (imizekelo: U-Enfamil AR Lipil kunye ne-Similac ephuculayo RS)
- I-formula ye-Soy - kwiintsana ezine-galactosemia, ukunyanzeliswa kwe-lactose, kunye nokunyanzeliswa kwe-protein yamanzi (imizekelo: Enfamil Prosobee Lipil, uNestle Good Start Soy Plus, kunye neSimilac Isomil Advance)
- Iifomula zeintsana zangaphambi kwexesha - zineekhalori ezingaphezulu kunye nezinye izondlo zokubeletha iintsana ezingaphantsi kwexesha lokuzalwa (imizekelo: Enfamil EnfaCare Lipil kunye ne-Similac Neosure)
- Isinyathelo esilandelayo okanye inkomfa encinane - kwiintsana ezincinane kunye nabantwana abaselula abaneminyaka engama-9 neye-24 ubudala (imizekelo: I-Enfamil Isinyathelo esilandelayo i-Lipil, iNestle Good Start Qinisekisa ngakumbi 2, kunye ne-Similac Hamba & Khula)
- Ifomula ye-Elemental - iintsana kunye neprotheni yobisi kunye ne-soy allergies (imizekelo: iNutramigen Lipil , Pregestamil Lipil, kunye neSimilac Alimentum)
- I-amino acid based formula - kwiintsana kunye neprotheni yobisi kunye ne-soy allergies ezingenako ukunyamezela i-formula element (imizekelo: i-Neocate ne-Nutramigen AA Lipil)
Ukuba umntwana wakho unenkinga yangempela kunye nefomula yakhe, ke ukhetha olunye uhlobo lwefomula lomntwana luba luleke. Ukutshintsha nje imveliso, ngaphandle kokuba utshintshe iifom zefomula, ayinakunceda, nangona kunjalo.
Nangona abazali bahlala besuka kolunye uhlobo lwefomula ukuya kwelinye xa iintsana zabo ziqhubeka zingakwazi ukunyamezela iifom zabo, kucinge ukuba kulungele ukuthetha nengane yakho ngaphambi kokuba utshintshe amafomula.
Iimpawu zokungahambisani ne-formula zingabandakanya ukugqithisa okungaxeliweyo, i-gas excessive, isifo sohudo (esingaba negazi), ukuhlambalaza, ukuhlanza kunye nokufumanisa ubunzima.
Ulwahlulo lwe-Baby Formula
Ukongezelela kwiintlobo ezahlukeneyo zefomula yomntwana, kukho ukungafani phakathi kweempawu phakathi kweendlela ezifanayo zefomula yomntwana.
Umzekelo, umehluko omnye phakathi kweSimilac Advance kunye ne-Enfamil Lipil kukuba iSimilac Advance ayisebenzisi i-palm olein i-oli njengomthombo wayo wamafutha, endaweni yoko, usebenzisa i-soy ne-coconut oil. Ngoxa abenzi beSimilac kunye nezinye iingcamango zibonisa ukuba i-olein yesoyile ye-palm iyanciphisa i-calcium kunye ne-bone mineralisation, abanye abenzi beendlela kunye nezinye izifundo eziphikisanayo nezibango.
Zombili i-Similac Advance kunye ne-Enfamil Lipil zihluke kwi-Nestle Good Start kwi-makeup ye-proteins yobisi.
Ngoxa i-Similac Advance ne-Enfamil Lipil zidibanisa ii-whey kunye neeprotheni ze-casein, njengobisi lwebele, i-Nestle Good Start yenziwe ngamaproteni ama-100% ('Induduzo yeeprotheni').
Ezinye izinto eziye zongezwa kwifomula yobutsha kungekudala ziquka:
- I-DHA ne-ARA-ngoku ikhona kwiimveliso ezininzi kunye neentlobo zefomula yomntwana, kuquka u-Enfamil Lipil, uNestle Good Start Start Gentle Plus, kunye ne-Similac Advance. Enyanisweni, i-Nestle Good Start Nourish Plus ibonakala iyona ifom yegama legama lomhlaba elisekhona ngaphandle kwe-DHA ne-ARA.
- I-Prebiotics - u-Enfamil IPHEEMIUM ne-Triple Health Guard kunye ne-Similac Advance EarlyShield
- Iprobiotics - iNutramigen nge-Enflora LGG kunye neNestle Good Start Protect Plus
- Antioxidants - I-Similac Advance EarlyShield kunye neNestle Good Start Qala Protect Plus
- Izithako ze-Organic - I-Similac ye-Organic and Organic Organic Form Formula
Zininzi zezi ntlobo zentsana zefomula zifumaneka kwii-formula zebhanki ze-brand brand, njenge-Bright Beginnings (CVS) kunye noKhetho lwabazali (i-Walmart), efana ne-esitolo esinezilwanyana zefomula ze-brand-eyenziwa yi-PBM Nutritionals.
Ukukhetha i-Formula yeBantwana
Nangona ubisi lwebele lubuthandayo kwindawo yokuqala phakathi kokusondeza i-formula kunye nokuncelisa, iingcali ezimbalwa ziza kukuxelela ukuba uluphi uhlobo lwefomula oluza okwesibini.
Iingcali ezimbalwa ziza kukuxelela ukuba awukwazi ukugcina imali ngokukhetha uhlobo oluthile lwe-brand brand yefowuni malunga nefomula yegama langoku. Gcina engqondweni ukuba akufanele uzame ukugcina imali ngokuhlalutya ifomula yomntwana. Naluphi na umntwana othenga ngawo, qhobela ngokulandelelana imiyalelo yokuxuba.
Imithombo:
> Koo WW. Ukunciphisa i-bone mineralized kwiintsana ezondla ifom ye-palm olein ene-formula: ityala elingabonakaliyo, eliphindwe kabini, elilindelekileyo. Izifo zonyango - 01-MAY-2003; 111 (5 Pt 1): 1017-23.
> RJ oselula. Ukunakekelwa kwabantwana abancinci kunye nosana: umphumo kwintlupheko yethambo eminyaka emine. J Pediatr Gastroenterol Nutrition - 01-JUL-2005; 41 (1): 88-93.